<DOC>
	<DOCNO>NCT02960828</DOCNO>
	<brief_summary>This study aim validate efficacy safety subthreshold laser photocoagulation high-risk macular drusen early age-related macular degeneration high risk conversion exudative AMD .</brief_summary>
	<brief_title>`` Stop Early Age-related Macular Degeneration ( AMD ) From Vision Loss Eternally '' Study</brief_title>
	<detailed_description>SAVE Study ( Stop Early Age-related Macular Degeneration form Vision Loss Eternally )</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Retinal Drusen</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Drusen eye examine fundoscopy At least one eye must highrisk soft drusen BCVA ETDRS 83 letter Patient consent participate Prior diagnosis choroidal neovascularization Exudative AMD least one eye If patient one visually effective eye ( last eye ) Other macula retinal disease agerelated macular degeneration</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>